Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Market Cap	11.06B
Revenue (ttm)	2.34B
Net Income (ttm)	416.50M
Shares Out	204.48M
EPS (ttm)	n/a
PE Ratio	26.56
Forward PE	21.85
Dividend	1.23 (2.24%)
Ex-Dividend Date	Nov 18, 2024

Volume	999,764
Average Volume	432,059
Open	54.50
Previous Close	54.85
Day's Range	53.95 - 54.95
52-Week Range	47.28 - 60.95
Beta	0.45
RSI	36.05
Earnings Date	Feb 21, 2025

About BIT:REC

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in Italy and internationally. It operates through Specialty and Primary Care and Rare Diseases segments. The company’s product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing’s syndrome; and CYSTADROPS for the treatment of cystine crystal deposits...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1926
• Employees: 4,450
• Stock Exchange: Borsa Italiana
• Ticker Symbol: REC

Financial Performance

In 2024, BIT:REC's revenue was 2.34 billion, an increase of 12.45% compared to the previous year's 2.08 billion. Earnings were 416.50 million, an increase of 7.01%.